Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
1.
Malar J ; 11: 355, 2012 Oct 26.
Article in English | MEDLINE | ID: mdl-23101492

ABSTRACT

BACKGROUND: By 2009, there were worrying signs from western Cambodia that parasitological responses to artesunate-containing treatment regimens for uncomplicated Plasmodium falciparum malaria were slower than elsewhere which suggested the emergence of artemisinin resistance. Vietnam shares a long land border with Cambodia with a large number of migrants crossing it on a daily basis. Therefore, there is an urgent need to investigate whether there is any evidence of a change in the parasitological response to the artemisinin derivatives in Vietnam. METHODS: From August 2010 to May 2011, a randomized controlled clinical trial in uncomplicated falciparum malaria was conducted to compare two doses of artesunate (AS) (2mg/kg/day versus 4 mg/kg/day for three days) followed by dihydroartemisinin-piperaquine (DHA-PPQ) and a control arm of DHA-PPQ. The goal was characterization of the current efficacy of artesunate in southern Vietnam. The primary endpoint of this study was the parasite clearance half-life; secondary endpoints included the parasite reduction ratios at 24 and 48 hours and the parasite clearance time. RESULTS: 166 patients were recruited into the study. The median parasite clearance half-lives were 3.54 (AS 2mg/kg), 2.72 (AS 4mg/kg), and 2.98 hours (DHA-PPQ) (p=0.19). The median parasite-reduction ratio at 24 hours was 48 in the AS 2mg/kg group compared with 212 and 113 in the other two groups, respectively (p=0.02). The proportions of patients with a parasite clearance time of >72 hours for AS 2mg/kg, AS 4mg/kg and DHA-PPQ were 27%, 27%, and 22%, respectively. Early treatment failure occurred in two (4%) and late clinical failure occurred in one (2%) of the 55 patients in the AS 2mg/kg group, as compared with none in the other two study arms. The PCR-corrected adequate clinical and parasitological response (APCR) rates in the three groups were 94%, 100%, and 100% (p=0.04). CONCLUSIONS: This study demonstrated faster P. falciparum parasite clearance in southern Vietnam than in western Cambodia but slower clearance in comparison with historical data from Vietnam. Further studies to determine whether this represents the emergence of artemisinin resistance in this area are needed. Currently, the therapeutic response to DHA-PPQ remains satisfactory in southern Vietnam. TRIAL REGISTRATION: NTC01165372.


Subject(s)
Antimalarials/administration & dosage , Artemisinins/administration & dosage , Drug Resistance , Malaria, Falciparum/drug therapy , Malaria, Falciparum/parasitology , Plasmodium falciparum/drug effects , Adolescent , Adult , Artesunate , Child , Female , Humans , Male , Plasmodium falciparum/isolation & purification , Quinolines/administration & dosage , Treatment Outcome , Vietnam , Young Adult
2.
Br J Haematol ; 150(3): 359-64, 2010 Aug.
Article in English | MEDLINE | ID: mdl-20497177

ABSTRACT

In order to obtain an approximate assessment of the public health burden that will be posed by the inherited disorders of haemoglobin in southern Vietnam, several thousand individuals were screened for these conditions. A smaller sample was screened for glucose-6-phosphate dehydrogenase (G6PD) deficiency. The important haemoglobin disorders identified were beta thalassaemia, haemoglobin E and a variety of different forms of alpha thalassaemia. There were sufficient G6PD-deficient individuals to materially affect malaria control programme design. The most remarkable finding was wide variation in the gene frequencies of these conditions among the ethnic groups sampled. The approximate number of babies expected to be born with clinically significant haemoglobin disorders in Vietnam was estimated from the gene-frequency data. This study emphasizes the importance of wide-scale population screening, including ethnic subgroups, to establish the requirements for inherited haemoglobin disorder programmes in resource-limited settings.


Subject(s)
Hemoglobinopathies/ethnology , Blood Specimen Collection/methods , Gene Frequency , Genotype , Glycogen Storage Disease Type I/ethnology , Glycogen Storage Disease Type I/genetics , Hemoglobin E/analysis , Hemoglobinopathies/genetics , Humans , Mass Screening/organization & administration , Mutation , Needs Assessment/organization & administration , Prevalence , Vietnam/epidemiology , alpha-Thalassemia/ethnology , alpha-Thalassemia/genetics , beta-Thalassemia/ethnology , beta-Thalassemia/genetics
4.
Am J Trop Med Hyg ; 94(4): 879-885, 2016 04.
Article in English | MEDLINE | ID: mdl-26856909

ABSTRACT

A total of 128 Vietnamese patients with symptomatic Plasmodium vivax mono-infections were enrolled in a prospective, open-label, randomized trial to receive either chloroquine or dihydroartemisinin-piperaquine (DHA-PPQ). The proportions of patients with adequate clinical and parasitological responses were 47% in the chloroquine arm (31 of 65 patients) and 66% in the DHA-PPQ arm (42 of 63 patients) in the Kaplan-Meier intention-to-treat analysis (absolute difference 19%, 95% confidence interval = 0-37%), thus establishing non-inferiority of DHA-PPQ. Fever clearance time (median 24 versus 12 hours,P= 0.02), parasite clearance time (median 36 versus 18 hours,P< 0.001), and parasite clearance half-life (mean 3.98 versus 1.80 hours,P< 0.001) were all significantly shorter in the DHA-PPQ arm. All cases of recurrent parasitemia in the chloroquine arm occurred from day 33 onward, with corresponding whole blood chloroquine concentration lower than 100 ng/mL in all patients. Chloroquine thus remains efficacious for the treatment of P. vivax malaria in southern Vietnam, but DHA-PPQ provides more rapid symptomatic and parasitological recovery.


Subject(s)
Antimalarials/therapeutic use , Artemisinins/therapeutic use , Chloroquine/therapeutic use , Malaria, Vivax/drug therapy , Plasmodium vivax/drug effects , Quinolines/therapeutic use , Antimalarials/administration & dosage , Artemisinins/administration & dosage , Drug Therapy, Combination , Female , Humans , Male , Quinolines/administration & dosage , Treatment Outcome , Vietnam , Young Adult
5.
Nat Genet ; 45(6): 648-55, 2013 Jun.
Article in English | MEDLINE | ID: mdl-23624527

ABSTRACT

We describe an analysis of genome variation in 825 P. falciparum samples from Asia and Africa that identifies an unusual pattern of parasite population structure at the epicenter of artemisinin resistance in western Cambodia. Within this relatively small geographic area, we have discovered several distinct but apparently sympatric parasite subpopulations with extremely high levels of genetic differentiation. Of particular interest are three subpopulations, all associated with clinical resistance to artemisinin, which have skewed allele frequency spectra and high levels of haplotype homozygosity, indicative of founder effects and recent population expansion. We provide a catalog of SNPs that show high levels of differentiation in the artemisinin-resistant subpopulations, including codon variants in transporter proteins and DNA mismatch repair proteins. These data provide a population-level genetic framework for investigating the biological origins of artemisinin resistance and for defining molecular markers to assist in its elimination.


Subject(s)
Antimalarials/pharmacology , Artemisinins/pharmacology , Genes, Protozoan , Malaria, Falciparum/parasitology , Plasmodium falciparum/genetics , Cambodia/epidemiology , Chromosome Painting , Cluster Analysis , Drug Resistance , Founder Effect , Genetic Association Studies , Homozygote , Humans , Malaria, Falciparum/drug therapy , Malaria, Falciparum/epidemiology , Models, Genetic , Plasmodium falciparum/drug effects , Polymorphism, Single Nucleotide , Principal Component Analysis
6.
PLoS One ; 6(3): e17604, 2011 Mar 08.
Article in English | MEDLINE | ID: mdl-21408132

ABSTRACT

BACKGROUND: Streptococcus suis infection, an emerging zoonosis, is an increasing public health problem across South East Asia and the most common cause of acute bacterial meningitis in adults in Vietnam. Little is known of the risk factors underlying the disease. METHODS AND FINDINGS: A case-control study with appropriate hospital and matched community controls for each patient was conducted between May 2006 and June 2009. Potential risk factors were assessed using a standardized questionnaire and investigation of throat and rectal S. suis carriage in cases, controls and their pigs, using real-time PCR and culture of swab samples. We recruited 101 cases of S. suis meningitis, 303 hospital controls and 300 community controls. By multivariate analysis, risk factors identified for S. suis infection as compared to either control group included eating "high risk" dishes, including such dishes as undercooked pig blood and pig intestine (OR(1) = 2.22; 95%CI = [1.15-4.28] and OR(2) = 4.44; 95%CI = [2.15-9.15]), occupations related to pigs (OR(1) = 3.84; 95%CI = [1.32-11.11] and OR(2) = 5.52; 95%CI = [1.49-20.39]), and exposures to pigs or pork in the presence of skin injuries (OR(1) = 7.48; 95%CI = [1.97-28.44] and OR(2) = 15.96; 95%CI = [2.97-85.72]). S. suis specific DNA was detected in rectal and throat swabs of 6 patients and was cultured from 2 rectal samples, but was not detected in such samples of 1522 healthy individuals or patients without S. suis infection. CONCLUSIONS: This case control study, the largest prospective epidemiological assessment of this disease, has identified the most important risk factors associated with S. suis bacterial meningitis to be eating 'high risk' dishes popular in parts of Asia, occupational exposure to pigs and pig products, and preparation of pork in the presence of skin lesions. These risk factors can be addressed in public health campaigns aimed at preventing S. suis infection.


Subject(s)
Streptococcal Infections/epidemiology , Streptococcus suis/physiology , Adult , Age Distribution , Animals , Carrier State/microbiology , Case-Control Studies , Female , Hospitals , Humans , Male , Middle Aged , Multivariate Analysis , Polymerase Chain Reaction , Risk Factors , Streptococcal Infections/microbiology , Streptococcus suis/genetics , Sus scrofa/microbiology , Vietnam/epidemiology
SELECTION OF CITATIONS
SEARCH DETAIL